NIH

Vical Biotech and NIH jointly develops HIV vaccine

A new HIV vaccine is being jointly developed by Vical Pharmaceuticals and the National Institute of Health (NIH). The new HIV vaccine was developed by the scientistis in NIH and the Federal government is using the Vical Biotechs DNA delivery technology to inserting the HIV genes//. Vical Inc. is a Biotechnology company based in California, which has developed an accurate DNA delivery sy...

NIH To Launch Two Major Gene and Disease Projects Soon

In order to better understand the role of genetic and environmental factors in the incidence of common diseases, the United States has planned to launch two major research studies// The National Institutes of Health (NIH) announced this recently. The link between genes, environment and the disease would form the main focus of the study. One of the projects would revolve around the sig...

NIH Funds the Development of National Consortium of Universities

A $100 million grant has been given to a dozen top universities on Tuesday by the government in order to set up a network// that would hasten scientific discoveries towards better health care thereby trying to transform how medical research is done. This idea came about because of the increased specialization in medicine which has made it more difficult than ever for scientists from d...

New data from NIH lab confirms protocol to reverse type 1 diabetes in mice

New data published in the Nov. 24 issue of Science supports the protocol to reverse type 1 diabetes in mice and there is proof now that adult precursor cells// from the spleen can add to the renewal of beta cells. In 2001 and 2003, researchers at Massachusetts General Hospital (MGH) showed the benefits of a procedure to turnaround type 1 diabetes in diabetic mice. Three studies from o...

Yale Child Study Center Receives NIH Grant for Autism Research

The Yale Child Study Center has received a $3.5 million National Institute of Child Health and Human Development grant for an ongoing, multidisciplinary research program// on autism and related developmental disorders. The five-year research program focuses on developmental aspects and outcomes for affected patients. The project includes a prospective study on the earliest manifestat...

NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease

The NIH National Institute of Neurological Disorders and Stroke (NINDS) today is launching a large-scale clinical trial to learn if the nutritional supplement creatine// can slow the progression of Parkinson's disease (PD). While creatine is not an approved therapy for PD or any other condition, it is widely thought to improve exercise performance. The potential benefit of creatine for PD...

NIH Study Normal Brain Development in Children Across US

Children appear to approach adult levels of performance on many basic cognitive and motor skills by age 11 or 12, according to a new study coordinated by the National Institutes of Health (NIH). The NIH Magnetic Resonance Imaging (MRI) Study of Normal Brain Development is tracking brain and behavioral development in about 500 healthy American children, from birth to age 18. A repor...

NIH Awards Emory $3.6 Million for Schizophrenia Gene Research

The National Institute of Mental Health of the National Institutes of Health has awarded Emory University School of Medicine a $3.6 million research grant to test schizophrenic patients for a recently discovered variation in the human genome. The project is led by Stephen T. Warren, PhD, Timmie Professor and chair of the Department of Human Genetics. Schizophrenia is a severe and c...